Antisense's multiple sclerosis candidate set to advance in China through academic JV deal
This article was originally published in Scrip
Executive Summary
Chinese academic institutions are increasingly becoming involved in co-operative alliances with foreign pharmaceutical companies as the latter seek to tap into the expertise and capabilities of the enormous academic research sector in China.